Showing results (71-80 of 219) with videos related to
Sort By:
Pageof 22
Critical Reviews in Oncology/Hematology|February 21, 2018
Review: Effectiveness of implementation strategies to increase physical activity uptake during and after cancer treatmentC IJsbrandy, P B Ottevanger, M Tsekou Diogeni, et al.Human Vaccines & Immunotherapeutics|November 27, 2014
Awareness and understanding of cancer immunotherapy in EuropeHåkan Mellstedt, Gustav Gaudernack, Winald R Gerritsen, et al.Journal of Virology|January 18, 2006
Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapterM H Verheije, T Würdinger, V W van Beusechem, et al.Journal of Cancer Survivorship : Research and Practice|July 27, 2019
Implementing physical activity programs for patients with cancer in current practice: patients' experienced barriers and facilitatorsCharlotte IJsbrandy, Rosella P M G Hermens, Laura W M Boerboom, et al.Gene Therapy|January 11, 2000
Recombinant adenovirus vectors with knobless fibers for targeted gene transferV W van Beusechem, A L van Rijswijk, H H van Es, et al.Transplantation|February 1, 1988
The repopulation capacity of bone marrow grafts following pretreatment with monoclonal antibodies against T lymphocytes in rhesus monkeysW R Gerritsen, G Wagemaker, M Jonker, et al.Human Gene Therapy|March 17, 2004
Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion proteinMichelle de Graaf, Herbert M Pinedo, Dinja Oosterhoff, et al.Blood|February 1, 1997
Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrinsI S Weimar, D de Jong, E J Muller, et al.Blood|July 1, 1992
Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridizationW R Gerritsen, J Donohue, J Bauman, et al.Journal for Immunotherapy of Cancer|June 1, 2021
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discoveryJeroen H A Creemers, W Joost Lesterhuis, Niven Mehra, et al.Pageof 22